Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.

NCT00308243 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Sodium Pyruvate in 0.9% Sodium Chloride Solution

Sponsor

Emphycorp

Collaborators

[object Object]